Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

Press/Media: Press / Media

PeriodMay 28 2019

Media coverage

1

Media coverage

  • TitleDocetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up
    Media name/outletThe Oncologist
    CountryUnited States
    Date5/28/19
    PersonsDevalingam Mahalingam
View all 1
View less